Europe clears blood test to predict Alzheimer’s disease
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
The programme will be implemented across 13 states and benefit 256 min
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Subscribe To Our Newsletter & Stay Updated